DK167531B1 - Pyrrolidinon- og oxazolidinonderivater og deres anvendelse til fremstilling af farmaceutiske praeparater - Google Patents

Pyrrolidinon- og oxazolidinonderivater og deres anvendelse til fremstilling af farmaceutiske praeparater Download PDF

Info

Publication number
DK167531B1
DK167531B1 DK288686A DK288686A DK167531B1 DK 167531 B1 DK167531 B1 DK 167531B1 DK 288686 A DK288686 A DK 288686A DK 288686 A DK288686 A DK 288686A DK 167531 B1 DK167531 B1 DK 167531B1
Authority
DK
Denmark
Prior art keywords
oxazolidinone
methyl
methoxyphenyl
mmol
general formula
Prior art date
Application number
DK288686A
Other languages
Danish (da)
English (en)
Other versions
DK288686D0 (da
DK288686A (da
Inventor
Walter Klose
Gerald Kirsch
Andreas Huth
Wolfgang Froehlich
Henry Laurent
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK288686D0 publication Critical patent/DK288686D0/da
Publication of DK288686A publication Critical patent/DK288686A/da
Application granted granted Critical
Publication of DK167531B1 publication Critical patent/DK167531B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B1/00—Engines characterised by fuel-air mixture compression
    • F02B1/02—Engines characterised by fuel-air mixture compression with positive ignition
    • F02B1/04—Engines characterised by fuel-air mixture compression with positive ignition with fuel-air mixture admission into cylinder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK288686A 1984-10-19 1986-06-19 Pyrrolidinon- og oxazolidinonderivater og deres anvendelse til fremstilling af farmaceutiske praeparater DK167531B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3438839 1984-10-19
DE19843438839 DE3438839A1 (de) 1984-10-19 1984-10-19 Pharmazeutische praeparate
DE8500472 1985-10-18
PCT/DE1985/000472 WO1986002268A1 (en) 1984-10-19 1985-10-18 Pharmaceutical preparations

Publications (3)

Publication Number Publication Date
DK288686D0 DK288686D0 (da) 1986-06-19
DK288686A DK288686A (da) 1986-06-19
DK167531B1 true DK167531B1 (da) 1993-11-15

Family

ID=6248597

Family Applications (1)

Application Number Title Priority Date Filing Date
DK288686A DK167531B1 (da) 1984-10-19 1986-06-19 Pyrrolidinon- og oxazolidinonderivater og deres anvendelse til fremstilling af farmaceutiske praeparater

Country Status (8)

Country Link
EP (1) EP0198919B1 (no)
JP (2) JPH0742229B2 (no)
AU (2) AU5095885A (no)
DE (2) DE3438839A1 (no)
DK (1) DK167531B1 (no)
FI (1) FI862590A0 (no)
NO (1) NO164897C (no)
WO (1) WO1986002268A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783591A (en) * 1984-10-19 1998-07-21 Schering Aktiengesellschaft Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation
US4681940A (en) * 1985-11-19 1987-07-21 American Home Products Corporation 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles
DE3639225A1 (de) * 1986-11-14 1988-05-19 Schering Ag Verwendung von 5-(subst. phenyl)-oxazolidinonderiaten als psychopharmaka
US4968707A (en) * 1987-06-10 1990-11-06 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
ES2057110T3 (es) * 1988-03-24 1994-10-16 Sankyo Co Utilizacion de isoxazolinonas como farmacos con accion sobre el cerebro.
WO1992002220A1 (en) * 1990-08-03 1992-02-20 Smithkline Beecham Corporation Tnf inhibitors
US5124455A (en) * 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
WO1996024350A1 (de) * 1995-02-10 1996-08-15 Schering Aktiengesellschaft Pharmazeutische präparate zur tnf-inhibition
DE19540475A1 (de) * 1995-10-20 1997-04-24 Schering Ag Chirale Methylphenyloxazolidinone
US6770658B2 (en) * 1998-09-09 2004-08-03 Inflazyme Pharmaceuticals Ltd. Substituted γ-phenyl-Δ-lactams and uses related thereto
DE60233884D1 (de) * 2001-10-16 2009-11-12 Memory Pharmaceutical Corp 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidon-derivate als pde-4-hemmer zur behandlung von neurologischen syndromen
WO2004098592A1 (ja) * 2003-05-06 2004-11-18 Senju Pharmaceutical Co. Ltd. オキサゾリジノン誘導体含有組成物
AR057218A1 (es) 2005-12-15 2007-11-21 Astra Ab Compuestos de oxazolidinona y su uso como pontenciadores del receptor metabotropico de glutamato

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413935A1 (de) * 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone
SU888821A3 (ru) * 1976-12-03 1981-12-07 Шеринг Аг (Инофирма) Способ получени 5-(замещенный фенил)-оксазолидинонов или их серусодержащих аналогов
DE2655369A1 (de) * 1976-12-03 1978-06-08 Schering Ag 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
JPH0742229B2 (ja) 1995-05-10
NO164897C (no) 1990-11-28
JP2669494B2 (ja) 1997-10-27
EP0198919A1 (de) 1986-10-29
NO862439L (no) 1986-06-18
WO1986002268A1 (en) 1986-04-24
JPS62501289A (ja) 1987-05-21
DE3576118D1 (de) 1990-04-05
DK288686D0 (da) 1986-06-19
AU4765390A (en) 1990-05-03
NO164897B (no) 1990-08-20
JPH0761978A (ja) 1995-03-07
EP0198919B1 (de) 1990-02-28
DE3438839A1 (de) 1986-04-24
AU5095885A (en) 1986-05-02
FI862590A (fi) 1986-06-17
FI862590A0 (fi) 1986-06-17
DK288686A (da) 1986-06-19
NO862439D0 (no) 1986-06-18

Similar Documents

Publication Publication Date Title
DK167531B1 (da) Pyrrolidinon- og oxazolidinonderivater og deres anvendelse til fremstilling af farmaceutiske praeparater
KR100244372B1 (ko) 신규한 면역 억제성 화합물
AU660623B2 (en) Novel immunosuppressive compounds
CA2511255C (en) 2-piperidone derivatives as prostaglandin agonists
JPH07501528A (ja) 性ステロイド活性阻害剤
EP0587756A1 (en) Novel immunosuppressive compounds
FR2514348A1 (fr) Nouveaux sels d'acides carboxyliques, procede pour leur preparation et compositions pharmaceutiques les contenant
WO1994024095A1 (en) Immunosuppressive agents
US5614544A (en) Oxazolidinedione derivatives and their use
JP2000256390A (ja) 性ステロイド活性を抑制するために用いるエストロゲン核誘導体の医薬組成物
FI93112B (fi) Menetelmä uusien kinolyylioksatsol-2-onien valmistamiseksi, jotka ovat käyttökelpoisia proteiinikinaasi C:n inhibiittoreina
MX2008007687A (es) Compuestos y métodos para inhibir la interacción de proteínas bcl con compañeros enlazantes.
US5254574A (en) New tetrazole derivatives, process for their preparation and their use
US4088760A (en) Testosterone 5α-reductase inhibitors
JPS6222986B2 (no)
JPH06511483A (ja) インドール類
WO1994016697A1 (fr) Association synergisante ayant un effet antagoniste des recepteurs nk1 et nk2
US5998453A (en) Oxazolidinone compounds and pharmaceutical preparation containing them
Antonini et al. Indolizine derivatives with biological activity IV: 3‐(2‐Aminoethyl)‐2‐methylindolizine, 3‐(2‐aminoethyl)‐2‐methyl‐5, 6, 7, 8‐tetrahydroindolizine, and their iv‐alkyl derivatives
FR2486076A1 (fr) Aminocyclopentanone amides, leur preparation et compositions pharmaceutiques qui les contiennent
EP0284202B1 (en) Substituted hydantoin compounds
JPH0840934A (ja) 利尿薬調製のためのニューロテンシン拮抗薬の使用およびニューロテンシン拮抗薬を含有する利尿薬組成物
US4132725A (en) Substituted 3,1-benzazasilin-4-ones
FR2551440A1 (fr) Aminocyclopentanes, leur procede de preparation et compositions pharmaceutiques les contenant
JP5516908B2 (ja) 神経細胞突起伸展作用を有する化合物

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired